The active search for a synergistic M&A partner by ReShape Lifesciences suggests a strategic initiative to enhance its business operations and market presence. This move is likely to be viewed positively by investors as it indicates potential for growth and expansion, thus potentially leading to an increase in the stock price in the short term.